CN116256513A - Single-person mixed flow antibody freeze-dried microchip detection reagent tube and preparation and application thereof - Google Patents
Single-person mixed flow antibody freeze-dried microchip detection reagent tube and preparation and application thereof Download PDFInfo
- Publication number
- CN116256513A CN116256513A CN202310268654.1A CN202310268654A CN116256513A CN 116256513 A CN116256513 A CN 116256513A CN 202310268654 A CN202310268654 A CN 202310268654A CN 116256513 A CN116256513 A CN 116256513A
- Authority
- CN
- China
- Prior art keywords
- antibody
- reagent tube
- freeze
- microchip
- lyophilized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 105
- 238000001514 detection method Methods 0.000 title claims abstract description 57
- 238000002360 preparation method Methods 0.000 title abstract description 7
- 238000007789 sealing Methods 0.000 claims abstract description 20
- 238000004108 freeze drying Methods 0.000 claims abstract description 15
- 239000000427 antigen Substances 0.000 claims abstract description 13
- 210000004027 cell Anatomy 0.000 claims description 54
- 229910052751 metal Inorganic materials 0.000 claims description 23
- 239000002184 metal Substances 0.000 claims description 21
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 20
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 15
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 15
- 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 claims description 14
- 238000012360 testing method Methods 0.000 claims description 13
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims description 12
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims description 12
- 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 claims description 12
- 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 claims description 12
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 claims description 12
- 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 claims description 12
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 claims description 12
- 102000036639 antigens Human genes 0.000 claims description 12
- 108091007433 antigens Proteins 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 229910052757 nitrogen Inorganic materials 0.000 claims description 10
- 239000012798 spherical particle Substances 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 9
- 102100036301 C-C chemokine receptor type 7 Human genes 0.000 claims description 8
- 101000716065 Homo sapiens C-C chemokine receptor type 7 Proteins 0.000 claims description 8
- 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 claims description 7
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 claims description 7
- 102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 claims description 7
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 claims description 6
- 102100027207 CD27 antigen Human genes 0.000 claims description 6
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 claims description 6
- 101000914511 Homo sapiens CD27 antigen Proteins 0.000 claims description 6
- 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 claims description 6
- 102100038081 Signal transducer CD24 Human genes 0.000 claims description 6
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 6
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 5
- 229930195725 Mannitol Natural products 0.000 claims description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 5
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 5
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 5
- 239000000594 mannitol Substances 0.000 claims description 5
- 235000010355 mannitol Nutrition 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 239000004743 Polypropylene Substances 0.000 claims description 3
- 238000003556 assay Methods 0.000 claims description 3
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims description 3
- -1 polypropylene Polymers 0.000 claims description 3
- 229920001155 polypropylene Polymers 0.000 claims description 3
- 239000010948 rhodium Substances 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims description 2
- 101710149863 C-C chemokine receptor type 4 Proteins 0.000 claims description 2
- 102100035875 C-C chemokine receptor type 5 Human genes 0.000 claims description 2
- 101710149870 C-C chemokine receptor type 5 Proteins 0.000 claims description 2
- 102100028990 C-X-C chemokine receptor type 3 Human genes 0.000 claims description 2
- 102100032976 CCR4-NOT transcription complex subunit 6 Human genes 0.000 claims description 2
- 102100032912 CD44 antigen Human genes 0.000 claims description 2
- 229910052684 Cerium Inorganic materials 0.000 claims description 2
- 229910052692 Dysprosium Inorganic materials 0.000 claims description 2
- 229910052691 Erbium Inorganic materials 0.000 claims description 2
- 229910052693 Europium Inorganic materials 0.000 claims description 2
- 229910052688 Gadolinium Inorganic materials 0.000 claims description 2
- 102100021260 Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 Human genes 0.000 claims description 2
- 229910052689 Holmium Inorganic materials 0.000 claims description 2
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims description 2
- 101000916050 Homo sapiens C-X-C chemokine receptor type 3 Proteins 0.000 claims description 2
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims description 2
- 101000894906 Homo sapiens Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 Proteins 0.000 claims description 2
- 101000994375 Homo sapiens Integrin alpha-4 Proteins 0.000 claims description 2
- 102100032818 Integrin alpha-4 Human genes 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 229910052765 Lutetium Inorganic materials 0.000 claims description 2
- 229910052779 Neodymium Inorganic materials 0.000 claims description 2
- 108010004729 Phycoerythrin Proteins 0.000 claims description 2
- 239000004793 Polystyrene Substances 0.000 claims description 2
- 229910052777 Praseodymium Inorganic materials 0.000 claims description 2
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 2
- 229910052772 Samarium Inorganic materials 0.000 claims description 2
- 241000973497 Siphonognathus argyrophanes Species 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- 229910052771 Terbium Inorganic materials 0.000 claims description 2
- 229910052775 Thulium Inorganic materials 0.000 claims description 2
- 229910052769 Ytterbium Inorganic materials 0.000 claims description 2
- 229920001893 acrylonitrile styrene Polymers 0.000 claims description 2
- 229910052797 bismuth Inorganic materials 0.000 claims description 2
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 claims description 2
- 229910052793 cadmium Inorganic materials 0.000 claims description 2
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 claims description 2
- 210000000170 cell membrane Anatomy 0.000 claims description 2
- GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical compound [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000007771 core particle Substances 0.000 claims description 2
- KBQHZAAAGSGFKK-UHFFFAOYSA-N dysprosium atom Chemical compound [Dy] KBQHZAAAGSGFKK-UHFFFAOYSA-N 0.000 claims description 2
- UYAHIZSMUZPPFV-UHFFFAOYSA-N erbium Chemical compound [Er] UYAHIZSMUZPPFV-UHFFFAOYSA-N 0.000 claims description 2
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 claims description 2
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 claims description 2
- KJZYNXUDTRRSPN-UHFFFAOYSA-N holmium atom Chemical compound [Ho] KJZYNXUDTRRSPN-UHFFFAOYSA-N 0.000 claims description 2
- 229910052738 indium Inorganic materials 0.000 claims description 2
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 claims description 2
- 230000003834 intracellular effect Effects 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 229910052746 lanthanum Inorganic materials 0.000 claims description 2
- FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 claims description 2
- OHSVLFRHMCKCQY-UHFFFAOYSA-N lutetium atom Chemical compound [Lu] OHSVLFRHMCKCQY-UHFFFAOYSA-N 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims description 2
- 239000002105 nanoparticle Substances 0.000 claims description 2
- QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 claims description 2
- 229910052763 palladium Inorganic materials 0.000 claims description 2
- 229910052697 platinum Inorganic materials 0.000 claims description 2
- 239000004417 polycarbonate Substances 0.000 claims description 2
- 229920000515 polycarbonate Polymers 0.000 claims description 2
- 239000004800 polyvinyl chloride Substances 0.000 claims description 2
- PUDIUYLPXJFUGB-UHFFFAOYSA-N praseodymium atom Chemical compound [Pr] PUDIUYLPXJFUGB-UHFFFAOYSA-N 0.000 claims description 2
- SCUZVMOVTVSBLE-UHFFFAOYSA-N prop-2-enenitrile;styrene Chemical compound C=CC#N.C=CC1=CC=CC=C1 SCUZVMOVTVSBLE-UHFFFAOYSA-N 0.000 claims description 2
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 claims description 2
- 239000002096 quantum dot Substances 0.000 claims description 2
- 239000011347 resin Substances 0.000 claims description 2
- 229920005989 resin Polymers 0.000 claims description 2
- 229910052703 rhodium Inorganic materials 0.000 claims description 2
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims description 2
- 229910052707 ruthenium Inorganic materials 0.000 claims description 2
- KZUNJOHGWZRPMI-UHFFFAOYSA-N samarium atom Chemical compound [Sm] KZUNJOHGWZRPMI-UHFFFAOYSA-N 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 claims description 2
- NAWDYIZEMPQZHO-UHFFFAOYSA-N ytterbium Chemical compound [Yb] NAWDYIZEMPQZHO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052727 yttrium Inorganic materials 0.000 claims description 2
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 claims description 2
- LLLVZDVNHNWSDS-UHFFFAOYSA-N 4-methylidene-3,5-dioxabicyclo[5.2.2]undeca-1(9),7,10-triene-2,6-dione Chemical compound C1(C2=CC=C(C(=O)OC(=C)O1)C=C2)=O LLLVZDVNHNWSDS-UHFFFAOYSA-N 0.000 claims 1
- 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 claims 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims 1
- 229920005372 Plexiglas® Polymers 0.000 claims 1
- 102100027208 T-cell antigen CD7 Human genes 0.000 claims 1
- 102100025237 T-cell surface antigen CD2 Human genes 0.000 claims 1
- 102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 claims 1
- 238000002493 microarray Methods 0.000 claims 1
- 229920002223 polystyrene Polymers 0.000 claims 1
- 229920000915 polyvinyl chloride Polymers 0.000 claims 1
- 230000007547 defect Effects 0.000 abstract description 4
- 238000004043 dyeing Methods 0.000 abstract description 3
- 239000012528 membrane Substances 0.000 abstract description 2
- 238000000684 flow cytometry Methods 0.000 description 13
- 210000004698 lymphocyte Anatomy 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- 210000001744 T-lymphocyte Anatomy 0.000 description 10
- 239000000872 buffer Substances 0.000 description 9
- 238000010186 staining Methods 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- 210000002865 immune cell Anatomy 0.000 description 8
- 238000004949 mass spectrometry Methods 0.000 description 7
- 210000005259 peripheral blood Anatomy 0.000 description 7
- 239000011886 peripheral blood Substances 0.000 description 7
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 6
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 6
- 230000000875 corresponding effect Effects 0.000 description 6
- 238000013394 immunophenotyping Methods 0.000 description 5
- 210000003071 memory t lymphocyte Anatomy 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 239000007853 buffer solution Substances 0.000 description 4
- 231100000433 cytotoxic Toxicity 0.000 description 4
- 230000001472 cytotoxic effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 210000002443 helper t lymphocyte Anatomy 0.000 description 4
- 239000011535 reaction buffer Substances 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000008098 formaldehyde solution Substances 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000007493 shaping process Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 2
- 102100022338 Integrin alpha-M Human genes 0.000 description 2
- 101710160107 Outer membrane protein A Proteins 0.000 description 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000000779 depleting effect Effects 0.000 description 2
- 239000012636 effector Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000012192 staining solution Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- 102000009410 Chemokine receptor Human genes 0.000 description 1
- 108050000299 Chemokine receptor Proteins 0.000 description 1
- 102000006354 HLA-DR Antigens Human genes 0.000 description 1
- 108010058597 HLA-DR Antigens Proteins 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010322 bone marrow transplantation Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 102000003675 cytokine receptors Human genes 0.000 description 1
- 108010057085 cytokine receptors Proteins 0.000 description 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006058 immune tolerance Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000004068 intracellular signaling Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 210000001806 memory b lymphocyte Anatomy 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000000441 neoplastic stem cell Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 210000003289 regulatory T cell Anatomy 0.000 description 1
- 238000005316 response function Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- FRNOGLGSGLTDKL-UHFFFAOYSA-N thulium atom Chemical compound [Tm] FRNOGLGSGLTDKL-UHFFFAOYSA-N 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention provides a single-person mixed flow antibody freeze-dried microchip detection reagent tube and preparation and application thereof. The detection reagent tube comprises a reagent tube (1), a freeze-drying micro-core (2) and a sealing membrane (3). The freeze-drying microchip is arranged at the bottom of the reagent tube, and the mouth of the reagent tube is sealed by a sealing film. The invention overcomes the defects of the prior art, simultaneously detects the multi-antigen markers on the sample at the single cell level, simplifies the reagents of experimental operation, achieves the standard antibody usage amount, ensures the accuracy and reliability of the detection result, has good stability especially at normal temperature, does not need cold chain transportation and storage, and reduces the cost and risk. The freeze-dried micro-core reagent tube is convenient and quick to use, shortens the time required by sample treatment, ensures the standardization of sample dyeing treatment, ensures the consistency of results and the accuracy of output results, and has great clinical application value.
Description
Technical Field
The invention relates to medical equipment, in particular to a single-person mixed flow type antibody freeze-dried microchip detection reagent tube and preparation and application thereof.
Background
Human immune cells are mainly of two major classes, lymphocytes and myeloid-derived non-lymphocytes. Lymphocytes are one of the white blood cells, and are the most important cellular components involved in the immune response function of the body. Early studies largely classified lymphocytes into T cells, B cells and natural killer cells based on their migration, surface molecules and functions. Wherein the T cells are further classified into cytotoxic T cells, helper T cells, regulatory T cells, memory T cells, etc.; b cells can be further divided into sub-cell populations such as primary B cells, plasma cells, and memory B cells.
With the continued progress of scientific research, the field of immunology has found hundreds of cell surface markers, specific antigens that appear or disappear during differentiation, maturation, and activation of cells of different lineages, called leukocyte differentiation antigens (CD molecules, cluster of Differentiation). These CD molecules are mainly adhesion molecules on the surface of immune cells, cytokine receptors or chemokine receptors, etc., and can be recognized by specific antibodies. These molecules have a high degree of variability in the different types of immune cells, which can be separated into finer sub-cellular taxonomies by analysis of these cell surface markers. For example, T cells can be further classified into helper T cells, helper depleting T cells, helper central memory T cells, helper effector memory T cells, cytotoxic helper T cells, cytotoxic depleting T cells, cytotoxic central memory T cells, and cytotoxic effector memory T cells, etc.
Immune cell typing is intimately involved in a variety of diseases. The absolute quantification of immune cell subpopulations or the relative quantification of various cell populations has great significance for judging pathological processes of various diseases such as autoimmune diseases, immunodeficiency diseases, malignant tumors, type I diabetes, inflammations, virus infections and the like, researching pathogenesis and monitoring the degree of immune system change in the diseases. Absolute counts of cd4+ T lymphocytes, for example, are clinically useful for disease staging in HIV-infected individuals, as well as for complications judgment; expression of HLA-DR on monocyte surfaces is positively correlated with prognosis in post-operative and post-traumatic patients; abnormal elevation of cd4+ T lymphocytes/cd8+ T lymphocytes ratio is common in rheumatoid arthritis, type I diabetes, and significant elevation of cd4+ T lymphocytes/cd8+ T lymphocytes ratio after organ transplantation suggests a higher likelihood of immune rejection; CD4+/CD25+/Foxp3+ T cells are important participants in immune tolerance, and abnormal numbers of the cells can lead to autoimmune diseases and can also be used as tracking before and after bone marrow transplantation.
The current methods for immune cell typing are mainly: immunological enzyme labeling method and flow cytometry method. The immune enzyme labeling method is based on antigen-antibody reaction to detect one or more markers carried by immune cells of a population, but the method cannot detect at single cell level, the number of required sample cells is large, multiple cell markers cannot be detected at the same time, and the method has the defects of narrow detection range, complex operation and the like. Flow cytometry can be used for carrying out fine enough subcellular group typing on immune cells at a single cell level through a plurality of antibody combination modes, and has relatively simple operation and wide application in clinic. The flow cytometry is to quantitatively analyze single cells or other biological ions at the cellular molecular level through monoclonal antibodies in a multi-parameter, high-flux and rapid manner, so that tens of thousands of cells can be analyzed at a high speed, and a plurality of parameters can be measured from one cell at the same time, and the flow cytometry has the advantages of high channel speed, high precision and good accuracy. Flow cytometry can achieve accurate immunophenotyping of cell populations, comprehensive analysis of intracellular signaling networks, analysis of functional relationships between cell subsets, and high throughput multiparameter detection of large numbers of samples. The method has wide application in research in various fields such as hematopoiesis, immunity, stem cells, cancer, drug screening and the like.
At present, the flow detection system is mainly divided into two major types, namely a typical flow cell detection system based on an optical detection system, and the detection principle is that cells are stained by using antibodies marked by fluorescein, and the analysis of different fluorescein excitation light spectrums is performed by using the optical detection system, so that the multiple protein levels of single cells are analyzed. The other type is a novel flow system based on a mass spectrum detection system, and the detection principle is that cells are stained by a metal element marked antibody, and the content of the metal element is analyzed by a mass spectrum detector so as to analyze the levels of various proteins of single cells. Both flow detection systems have the characteristics of multiple channels, high analysis speed and high sensitivity. However, in the existing test schemes, several indexes, even up to forty indexes, are detected simultaneously, which results in that when the sample is dyed, more than forty kinds of single liquid antibodies need to be added into the sample to be detected one by one and in a trace amount, and the process is complex in operation and takes a long time. Due to the long exposure of liquid antibodies in the environment, part of the antibodies can also have repeated freeze thawing, which is detrimental to long-term stable storage of the antibodies and transport. Otherwise, the temperature rise and repeated freezing and thawing in any process can cause the decline of the detection performance of the reagent, and the detection sensitivity is affected, so that the judgment of the result is affected. Thus, the research of the single-person mixed flow antibody freeze-dried microchip reagent tube is of great significance.
Disclosure of Invention
The invention aims to overcome the defects, and designs a single-person mixed flow antibody reagent which is simple to operate, high in detection efficiency and free from cold chain preservation.
The invention provides a single-person mixed flow antibody freeze-dried microchip detection reagent tube and preparation and application thereof.
The invention provides a single-person mixed flow antibody freeze-dried microchip detection reagent tube which comprises a reagent tube 1, a freeze-dried microchip 2 and a sealing film 3 (see figure 1). The freeze-drying microchip is arranged at the bottom of the reagent tube, and the mouth of the reagent tube is sealed by a sealing film. The lyophilized microchip reagent contains a volume of lyophilized excipient equal to the antibody, and the volume of the lyophilized microchip is 5 microliters to 60 microliters, preferably 25 microliters.
The diameter of the reagent tube is 12mm, the height of the reagent tube is 75mm, and the reagent tube is a common consumable for a commercially available conventional matched classical flow cytometer and mass spectrometer.
The reagent tube can be applied to detection of classical flow cytometry and mass flow cytometry.
The invention further aims to provide a preparation method of the single-person mixed flow type antibody freeze-dried microchip detection reagent tube.
The method comprises the following steps:
(1) Mixing the antibody mixture with a lyophilization excipient; the lyophilized microchip reagent contains a lyophilization excipient in the same volume as the antibody;
(2) Dropping the mixed solution into liquid nitrogen through a micro needle to naturally form spherical particles, and freeze-drying to obtain freeze-dried micro core particles; the liquid nitrogen temperature is-196 ℃, and the volume of the spherical particles is 5 microliters to 60 microliters, preferably 25 microliters.
(3) And sub-packaging the freeze-dried micro-cores at the bottom of the flow tube, and sealing the tube mouth with a sealing film to obtain the reagent tube for containing the freeze-dried micro-core reagent.
The reagent tube for containing the freeze-dried micro-core reagent is made of polypropylene (PP), polyvinyl chloride (PVC), polystyrene (PS), acrylonitrile styrene copolymer (SAN), transparent resin (ABS), polyethylene terephthalate (PET), polycarbonate (PC) or organic glass (PMMA). The diameter of the reagent tube is 12mm, the height is 75mm, and the reagent tube can be suitable for common fluorescence flow cytometry and mass flow cytometry.
The lyophilized micro core reagent includes four to sixty antibodies, the antibody species is not limited, and the antibodies are selected from antibodies which specifically bind to cell membrane surface antigens, extracellular factors, intracellular factors or nuclear factors, preferably antibodies such as CD2 antibodies, CD5 antibodies, CD7 antibodies, CD25 antibodies, CD44 antibodies, CD57 antibodies, CD49d antibodies, CD127 antibodies, CD161 antibodies, CCR7 antibodies, CXCR3 antibodies, CCR4 antibodies, CCR5 antibodies, CCR7 antibodies, CD3 antibodies, CD4 antibodies, CD8 antibodies, CD16 antibodies, CD19 antibodies, CD20 antibodies, CD56 antibodies, CD45RA antibodies, CD45RO antibodies, TCR- γδ antibodies, CD24 antibodies, CD27 antibodies, CD38 antibodies or IgD antibodies.
The antibodies are respectively marked with different labels, and the labels are fluorescein labels, metal element labels or quantum dots, nano particles and the like.
The fluorescein tag may be selected from the group including, but not limited to, fluorescein isothiocyanate FITC, phycoerythrin PE, polymethylchlorophyll protein PerCP or propidium iodide PI, the metal element tag is selected from the group consisting of metal elements or isotopes thereof: preferably yttrium Y, ruthenium Ru, rhodium Rh, palladium Pd, cadmium Cd, indium In, lanthanum La, cerium Ce, praseodymium Pr, neodymium Nd, samarium Sm, europium Eu, gadolinium Gd, terbium Tb, dysprosium Dy, holmium Ho, erbium Er, thulium Tm, ytterbium Yb, lutetium Lu, platinum Pt or bismuth Bi.
The freeze-drying excipient is selected from one or more of glycerin, trehalose, sucrose, mannitol or lactose.
The invention also aims to provide the application of the single-person mixed flow antibody freeze-dried microchip detection reagent tube. The application is in detecting cells.
When the freeze-dried microchip reagent tube containing the flow antibody is used, 100 microliters of single cell suspension to be detected is directly added into the reagent tube, vortex oscillation is carried out for 10 seconds to dissolve, incubation is carried out for 30 minutes at 15-25 ℃,1 milliliter of buffer solution such as phosphate buffer solution, cell staining solution, membrane breaking solution and the like is used, preferably, 500g of cell staining solution is centrifuged for 10 minutes, supernatant is discarded, the supernatant is repeated once, redundant antibody is washed, and the suspension is resuspended according to the required cell concentration by using the buffer solution, so that the suspension can be detected on a machine.
The invention overcomes the defects of the prior art, and avoids the conditions of transportation and preservation of the convection type antibody reagent and the harsh requirements on a cold chain. The single mixed flow antibody freeze-dried microchip detection tube has good stability at normal temperature, high precision, long storage period, no need of cold chain transportation and storage, no need of evaluating the bottle opening validity period, and reduced management cost and risk; the packaging of single reaction components is uniformly dissolved in buffer solution at once, so that the loss is avoided, the use is simple and convenient, the use cost is greatly reduced, and the method is particularly suitable for basic research laboratories, basic medical institutions and inspection institutions with poor cold chain transportation and storage conditions. Moreover, the freeze-dried micro-core reagent tube uses the sealing film to seal the reagent tube, and can be added into a sample to be detected for detection only through mechanical puncture, so that the method is convenient and quick, the workload that a plurality of antibodies are added into the sample to be detected one by one is greatly reduced, the time required by sample treatment is shortened, the standardization of sample dyeing treatment is ensured, the consistency of results is ensured, and the accuracy of output results is ensured. Has great clinical application value.
Drawings
FIG. 1 is a schematic diagram of a single-person mixed flow antibody freeze-dried microchip detection reagent tube structure.
Fig. 2: example 5 a single-serving, mixed-flow antibody lyophilized microchip test of the present invention was compared to the consistency of prior art antibody solutions.
The left graph shows the results of cell surface antigen detection by the single-person mixed flow antibody freeze-dried microchip.
The right panel shows the results of single liquid antibody detection of cell surface antigens in the prior art.
Fig. 3: example 6 stability of Single-serve hybrid flow antibody lyophilized Microchips of the invention at different temperatures
Detailed Description
The materials and reagents used in this example were all commercially available unless otherwise indicated.
Example 1
Referring to FIG. 1, the preparation of the single-person mixed flow antibody freeze-dried microchip detection reagent tube of the invention
The single mixed flow type antibody freeze-dried microchip detection reagent tube in the embodiment is a freeze-dried microchip detection reagent tube for lymphocyte TBNK cell typing in human peripheral blood, wherein the antibody amount for preparing the freeze-dried microchip detection reagent is as follows:
identifying target points | Antibody name | Metal label | Antibody content | Antibody concentration | Antibody volume |
CD3 | Anti-human CD3 antibodies | 154Sm | 100 micrograms | 500 micrograms/milliliter | 200 microliters |
CD4 | Anti-human CD4 antibodies | 173Yb | 100 micrograms | 500 micrograms/milliliter | 200 microliters |
CD8 | Anti-human CD8 antibodies | 168Er | 100 micrograms | 500 micrograms/milliliter | 200 microliters |
CD19 | Anti-human CD19 antibodies | 165Ho | 100 micrograms | 500 micrograms/milliliter | 200 microliters |
CD16 | Anti-human CD16 antibodies | 145Nd | 100 micrograms | 500 micrograms/milliliter | 200 microliters |
CD56 | Anti-human CD56 antibodies | 151Eu | 100 micrograms | 500 micrograms/milliliter | 200 microliters |
Fully mixing all antibody components according to the table, wherein the total volume of the mixed antibody is 1200 microliters, taking an equal volume (namely 1200 microliters) of freeze-drying excipient which is a mixture of 20% of trehalose and 8% of mannitol, fully and uniformly mixing the freeze-drying excipient with the mixed antibody solution, uniformly dividing the mixed liquid into 100 parts, wherein the volume of each part is 24 microliters, each part is one reaction system dosage, and dripping the mixture into liquid nitrogen according to each reaction system dosage for shaping; and then freezing and drying; the freeze-dried micro-core reagent for the typing of peripheral blood lymphocytes is obtained, the freeze-dried micro-core reagent is in the form of white spherical particles and has the volume of 24 microliters, and each tube is divided into 5 milliliter flow tubes according to one reaction dosage, namely, one white spherical particle per tube. In order to prevent the reagent from being wetted, the freeze-dried reagent is subjected to nitrogen protection treatment, and then a sealing film is added at the mouth of the flow pipe to carry out sealing treatment. The freeze-dried micro-core reagent tube containing the flow antibody is prepared.
The single-serving mixed flow antibody lyophilized microchip test reagent tube of this example 1 is a lyophilized microchip test reagent tube for lymphocyte immunophenotyping in human peripheral blood, wherein the amounts of antibodies used to make the lyophilized microchip test reagents are listed in the following table:
fully mixing all antibody components according to the table, wherein the total volume of the mixed antibody is 850 microliters, taking an equal volume (namely 850 microliters) of freeze-dried excipient, wherein the freeze-dried excipient is a mixture of 20% of trehalose and 8% of mannitol, fully and uniformly mixing the freeze-dried excipient and the mixed antibody solution, uniformly dividing the mixed liquid into 100 parts, wherein the volume of each part is 17 microliters, each part is one reaction system dosage, and dripping the mixture into liquid nitrogen according to each reaction system dosage for shaping; and then freezing and drying; the freeze-dried micro-core reagent for the typing of peripheral blood lymphocytes is obtained, the freeze-dried micro-core reagent is in the form of white spherical particles and has the volume of 17 microliters, and each tube is divided into 5 milliliter flow tubes according to one reaction dosage, namely, one white spherical particle per tube. In order to prevent the reagent from being wetted, the freeze-dried reagent is subjected to nitrogen protection treatment, and then a sealing film is added at the mouth of the flow pipe to carry out sealing treatment. The freeze-dried micro-core reagent tube containing the flow antibody is prepared.
Example 3
The single-serving mixed flow antibody lyophilized microchip detection reagent tube in this embodiment is a lyophilized microchip detection reagent tube for murine spleen lymphocyte immunophenotyping, wherein the amounts of antibodies used to make the lyophilized microchip detection reagent are listed in the following table:
identifying target points | Antibody name | Metal label | Antibody content | Antibody concentration | Antibody volume |
CD45 | Anti-murine CD45 antibodies | 147Sm | 100 micrograms | 500 micrograms/milliliter | 200 microliters |
CD11b | Anti-murine CD11b antibodies | 148Nd | 100 micrograms | 500 micrograms/milliliter | 200 microliters |
CD3e | Anti-murine CD3e antibodies | 152Sm | 100 micrograms | 500 micrograms/milliliter | 200 microliters |
CD8a | Anti-murine CD8a antibodies | 168Er | 100 micrograms | 500 micrograms/milliliter | 200 microliters |
CD4 | Anti-murine CD4 antibodies | 172Yb | 100 micrograms | 500 micrograms/milliliter | 200 microliters |
CD45R | Anti-murine CD45R antibodies | 176Yb | 100 micrograms | 500 micrograms/milliliter | 200 microliters |
Fully mixing all antibody components according to the table, wherein the total volume of the mixed antibody is 1200 microliters, taking an equal volume (namely 1200 microliters) of freeze-drying excipient which is a mixture of 20% of trehalose and 8% of mannitol, fully and uniformly mixing the freeze-drying excipient with the mixed antibody solution, uniformly dividing the mixed liquid into 100 parts, wherein the volume of each part is 24 microliters, each part is one reaction system dosage, and dripping the mixture into liquid nitrogen according to each reaction system dosage for shaping; and then freezing and drying; the freeze-dried micro-core reagent for the typing of peripheral blood lymphocytes is obtained, the freeze-dried micro-core reagent is in the form of white spherical particles and has the volume of 24 microliters, and each tube is divided into 5 milliliter flow tubes according to one reaction dosage, namely, one white spherical particle per tube. In order to prevent the reagent from being wetted, the freeze-dried reagent is subjected to nitrogen protection treatment, and then a sealing film is added at the mouth of the flow pipe to carry out sealing treatment. The freeze-dried micro-core reagent tube containing the flow antibody is prepared.
EXAMPLE 4 use of the invention in detecting cells
Mixed flow type antibody freeze-dried microchip detection reagent tube for single-person lymphocyte TBNK cell typing in human peripheral blood prepared in example 1
Wherein the following antibodies are included:
identifying target points | Antibody name | Metal label |
CD3 | Anti-human CD3 antibodies | 154Sm |
CD4 | Anti-human CD4 antibodies | 173Yb |
CD8 | Anti-human CD8 antibodies | 168Er |
CD19 | Anti-human CD19 antibodies | 165Ho |
CD16 | Anti-human CD16 antibodies | 145Nd |
CD56 | Anti-human CD56 antibodies | 151Eu |
When the detection is used, the diameter of the reagent tube 1 is 12mm, and the height is 75mm, so that the reagent tube can be suitable for common classical flow cytometry and mass flow cytometry. Removing the sealing film 3, opening a reagent tube containing the freeze-dried microchip, transferring a single cell suspension sample into the reagent tube 1, wherein the sample to be tested comprises cells to be tested and a reaction buffer solution, and the reaction buffer solution can enable the freeze-dried microchip 2 to be quickly redissolved. Vortex shaking for 10 seconds to fully dissolve and mix the freeze-dried microchip 2, and incubating for 30 minutes at room temperature (15-25 ℃);
washing the cells with 2 ml of staining buffer, centrifuging at 4deg.C for 5 min, discarding the supernatant, and repeating for 2 times; the resulting cell pellet was added to 100. Mu.l of 4% formaldehyde solution, fixed at room temperature (15-25 ℃) for 10 minutes, the cells were washed by adding 2 ml of staining buffer, repeated 2 times, and resuspended in 1 ml of staining buffer, ready for detection. Detecting the marked cell sample through a mass spectrometry flow system, wherein an original data signal output by the mass spectrometry flow system is a metal atom abundance signal of a metal element tag, and converting the original data signal into expression abundance information of a corresponding target protein in the cell according to the metal tag information carried by the corresponding antibody. Further analysis gave the antigen expression results of the cells.
Example 5 comparison with the prior art
The invention is used for single-person mixed flow type antibody freeze-dried microchip detection reagent tube detection of lymphocyte immunophenotyping in human peripheral blood
Comparison with the identity of prior art antibody solutions.
Referring to fig. 1, the single-person mixed flow antibody lyophilized microchip test reagent tube of this example 1 is a lyophilized microchip test reagent tube for lymphocyte immunophenotyping in human peripheral blood, which comprises the following antibodies:
identifying target points | Antibody name | Metal label |
CD45 | Anti-human CD45 antibodies | 142Nd |
CD3 | Anti-human CD3 antibodies | 154Sm |
CD4 | Anti-human CD4 antibodies | 173Yb |
CD8 | Anti-human CD8 antibodies | 168Er |
CD25 | Anti-human CD25 antibodies | 160Gd |
CD127 | Anti-human CD127 antibodies | 139La |
CD45RA | Anti-human CD45RA antibodies | 155Gd |
CD45RO | Anti-human CD45RO antibodies | 164Dy |
CCR7 | Anti-human CCR7 antibodies | 161Dy |
TCRγδ | Anti-human TCRγδ antibodies | 171Yb |
CD19 | Anti-human CD19 antibodies | 159Tb |
IgD | Anti-human IgD antibodies | 169Tm |
CD27 | Anti-human CD27 antibodies | 167Er |
CD24 | Anti-human CD24 antibodies | 174Yb |
CD38 | Anti-human CD38 antibodies | 175Lu |
CD16 | Anti-human CD16 antibodies | 145Nd |
CD56 | Anti-human CD56 antibodies | 149Sm |
When in use and detection, a single mixed flow antibody freeze-dried microchip detection reagent tube is taken, the diameter of the reagent tube is 12mm, and the height of the reagent tube is 75mm, so that the reagent tube can be suitable for common classical flow cytometry and mass spectrometry flow cytometry. Removing the sealing film 3, opening a reagent tube containing the freeze-dried microchip, transferring a single cell suspension sample into the reagent tube 1, wherein the sample to be tested comprises cells to be tested and a reaction buffer solution, and the reaction buffer solution can enable the freeze-dried microchip 2 to be quickly redissolved. Vortex shaking for 10 seconds to fully dissolve and mix the freeze-dried microchip 2, and incubating for 30 minutes at room temperature (15-25 ℃); washing the cells with 2 ml of staining buffer, centrifuging at 4deg.C for 5 min, discarding the supernatant, and repeating for 2 times; the resulting cell pellet was added to 100. Mu.l of 4% formaldehyde solution, fixed at room temperature (15-25 ℃) for 10 minutes, the cells were washed by adding 2 ml of staining buffer, repeated 2 times, and resuspended in 1 ml of staining buffer, ready for detection. Detecting the marked cell sample through a mass spectrometry flow system, wherein an original data signal output by the mass spectrometry flow system is a metal atom abundance signal of a metal element tag, and converting the original data signal into expression abundance information of a corresponding target protein in the cell according to the metal tag information carried by the corresponding antibody. Further analysis gave the antigen expression results of the cells.
The prior art uses the following method to detect:
identifying target points | Antibody name | Metal label |
CD45 | Anti-human CD45 antibodiesBody | 142Nd |
CD3 | Anti-human CD3 antibodies | 154Sm |
CD4 | Anti-human CD4 antibodies | 173Yb |
CD8 | Anti-human CD8 antibodies | 168Er |
CD25 | Anti-human CD25 antibodies | 160Gd |
CD127 | Anti-human CD127 antibodies | 139La |
CD45RA | Anti-human CD45RA antibodies | 155Gd |
CD45RO | Anti-human CD45RO antibodies | 164Dy |
CCR7 | Anti-human CCR7 antibodies | 161Dy |
TCRγδ | Anti-human TCRγδ antibodies | 171Yb |
CD19 | Anti-human CD19 antibodies | 159Tb |
IgD | Anti-human IgD antibodies | 169Tm |
CD27 | Anti-human CD27 antibodies | 167Er |
CD24 | Anti-human CD24 antibodies | 174Yb |
CD38 | Anti-human CD38 antibodies | 175Lu |
CD16 | Anti-human CD16 antibodies | 145Nd |
CD56 | Anti-human CD56 antibodies | 149Sm |
In the detection process, adding the liquid mixed antibodies in the table into the sample to be detected one by one according to the dosage, and incubating for 30 minutes at room temperature (15-25 ℃) after fully and uniformly mixing; washing the cells with 2 ml of staining buffer, centrifuging at 4deg.C for 5 min, discarding the supernatant, and repeating for 2 times; the resulting cell pellet was added to 100. Mu.l of 4% formaldehyde solution, fixed at room temperature (15-25 ℃) for 10 minutes, the cells were washed by adding 2 ml of staining buffer, repeated 2 times, and resuspended in 1 ml of staining buffer, ready for detection. Detecting the marked cell sample through a mass spectrometry flow system, wherein an original data signal output by the mass spectrometry flow system is a metal atom abundance signal of a metal element tag, and converting the original data signal into expression abundance information of a corresponding target protein in the cell according to the metal tag information carried by the corresponding antibody. Further analysis gave the antigen expression results of the cells.
From FIG. 2, it can be seen that the single-person mixed flow antibody lyophilized microchip of the present invention shows the same results as the cell antigen expression obtained from the prior art antibody solution. The left graph shows the result of detecting the cell surface antigen by single-person mixed flow antibody freeze-dried microchip detection.
The right panel shows the results of single liquid antibody detection of cell surface antigens in the prior art.
Example 6 stability of Single-serve hybrid flow antibody lyophilized Microchips of the invention at different temperatures
The single-serving mixed flow antibody lyophilized microchip test reagent tube of this example 1 is a lyophilized microchip test reagent tube for lymphocyte TBNK cell typing in human peripheral blood, which comprises the following antibodies:
a liquid mix assay for the genotyping of lymphocytes TBNK cells in human peripheral blood for comparison comprising the following antibodies:
identifying target points | Antibody name | Metal label |
CD3 | Anti-human CD3 antibodies | 154Sm |
CD4 | Anti-human CD4 antibodies | 173Yb |
CD8 | Anti-human CD8 antibodies | 168Er |
CD19 | Anti-human CD19 antibodies | 165Ho |
CD16 | Anti-human CD16 antibodies | 145Nd |
CD56 | Anti-human CD56 antibodies | 151Eu |
The single-person mixed flow antibody freeze-dried microchip detection reagent tube is stored for 50 days at the temperature of minus 20 ℃,4 ℃,25 ℃ (room temperature) and 37 ℃ respectively, then the same sample is detected by reagents with different storage conditions respectively, and the detected expression conditions of the cell surface CD4 and CD8 antigens are analyzed, and as can be seen from figure 3, the single-person mixed flow antibody freeze-dried microchip detection reagent tube is consistent in the performance and the result of the cell surface CD4 and CD8 antigen detection after being stored for 50 days at the temperature of minus 20 ℃,4 ℃,25 ℃ (room temperature) and 37 ℃ respectively.
The invention has the beneficial effects that:
the single-person mixed flow antibody freeze-dried microchip detection tube has good stability, high precision and long storage period at normal temperature, does not need cold chain transportation and storage, does not need evaluation of the bottle opening validity period, and reduces management cost and risk; the packaging of single reaction components is uniformly dissolved in buffer solution at once, so that the loss is avoided, the use is simple and convenient, the use cost is greatly reduced, and the method is particularly suitable for basic research laboratories, basic medical institutions and inspection institutions with poor cold chain transportation and storage conditions. Moreover, the freeze-dried micro-core reagent tube uses the sealing film to seal the reagent tube, and can be added into a sample to be detected for detection only by mechanical puncture, so that the method is convenient and quick, the workload that a plurality of antibodies are added into the sample to be detected one by one is greatly reduced, the time required by sample treatment is shortened, the standardization of sample dyeing treatment is ensured, the consistency of results is ensured, and the accuracy of output results is ensured.
Claims (10)
1. The single-person mixed flow type antibody freeze-dried microchip detection reagent tube is characterized by comprising a reagent tube 1, a freeze-dried microchip 2 and a sealing film 3.
2. The single-serving mixed flow antibody lyophilized microchip test reagent tube of claim 1, wherein the lyophilized microchip reagent contains a volume of lyophilized excipient equal to the antibody; the freeze-drying excipient is selected from one or more of glycerol, trehalose, sucrose, mannitol or lactose; the volume of the lyophilized microcores is from 5 microliters to 60 microliters, preferably 25 microliters; the diameter of the reagent tube is 12mm, and the height is 75mm.
3. A method of preparing a single-serving, mixed flow antibody lyophilized microchip test reagent tube as defined in claim 1, comprising the steps of:
(1) Mixing the antibody mixture with a lyophilization excipient; the lyophilized microchip reagent contains a lyophilization excipient in the same volume as the antibody;
(2) Dropping the mixed solution into liquid nitrogen through a micro needle to naturally form spherical particles, and freeze-drying to obtain freeze-dried micro core particles; the liquid nitrogen temperature is-196 ℃, and the volume of the spherical particles is 5 microliters to 60 microliters, preferably 25 microliters.
(3) And sub-packaging the freeze-dried micro-cores at the bottom of the flow tube, and sealing the tube mouth with a sealing film to obtain the reagent tube for containing the freeze-dried micro-core reagent.
4. The single-person mixed flow antibody lyophilized micro-core detection reagent tube according to claim 1, wherein the reagent tube for containing the lyophilized micro-core reagent is made of a material selected from the group consisting of polypropylene, polyvinyl chloride, polystyrene, acrylonitrile-styrene copolymer, transparent resin, ethylene terephthalate, polycarbonate and plexiglass.
5. The single-serving mixed flow antibody lyophilized microchip test reagent tube of claim 1, wherein the lyophilized microchip reagent comprises four to sixty antibodies; the antibody is selected from an antibody that specifically binds a cell membrane surface antigen, an extracellular factor, an intracellular factor, or a nuclear factor.
6. The single-serving mixed flow antibody lyophilized microarray assay tube of claim 5, wherein the antibody is a CD2 antibody, a CD5 antibody, a CD7 antibody, a CD25 antibody, a CD44 antibody, a CD57 antibody, a CD49d antibody, a CD127 antibody, a CD161 antibody, a CCR7 antibody, a CXCR3 antibody, a CCR4 antibody, a CCR5 antibody, a CCR7 antibody, a CD3 antibody, a CD4 antibody, a CD8 antibody, a CD16 antibody, a CD19 antibody, a CD20 antibody, a CD56 antibody, a CD45RA antibody, a CD45RO antibody, a TCR- γδ antibody, a CD24 antibody, a CD27 antibody, a CD38 antibody, or an IgD antibody.
7. The single-serving mixed flow antibody lyophilized microchip test reagent tube of claim 5, wherein the antibodies are labeled with different labels, respectively, which are fluorescein labels, metal element labels, or quantum dots or nanoparticles.
8. The single-person mixed flow antibody freeze-dried microchip detection reagent tube according to claim 7, wherein the fluorescein label is selected from fluorescein isothiocyanate, phycoerythrin, polymethylchlorophyll protein or propidium iodide; the metal element tag is selected from metal elements or isotopes thereof: preferably yttrium, ruthenium, rhodium, palladium, cadmium, indium, lanthanum, cerium, praseodymium, neodymium, samarium, europium, gadolinium, terbium, dysprosium, holmium, erbium, thulium, ytterbium, lutetium, platinum Pt or bismuth Bi.
9. Use of the single-serving, mixed-flow antibody lyophilized microchip assay reagent tube of claim 1.
10. Use of a single-serving, mixed flow antibody lyophilized microchip detection reagent tube according to claim 9, characterized in that the use is in detecting cells on a fluorescence flow cytometer or mass spectrometer.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310268654.1A CN116256513A (en) | 2023-03-20 | 2023-03-20 | Single-person mixed flow antibody freeze-dried microchip detection reagent tube and preparation and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310268654.1A CN116256513A (en) | 2023-03-20 | 2023-03-20 | Single-person mixed flow antibody freeze-dried microchip detection reagent tube and preparation and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116256513A true CN116256513A (en) | 2023-06-13 |
Family
ID=86687898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310268654.1A Pending CN116256513A (en) | 2023-03-20 | 2023-03-20 | Single-person mixed flow antibody freeze-dried microchip detection reagent tube and preparation and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116256513A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117384289A (en) * | 2023-11-09 | 2024-01-12 | 济南金域医学检验中心有限公司 | Antibody combination and kit for detecting T cell large granule lymphocyte and application of antibody combination and kit |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5759774A (en) * | 1988-05-18 | 1998-06-02 | Cobe Laboratories, Inc. | Method of detecting circulating antibody types using dried or lyophilized cells |
US20090061478A1 (en) * | 2006-01-30 | 2009-03-05 | Lene Have Poulsen | High-Speed Quantification of Antigen Specific T-Cells in Whole Blood by Flow Cytometry |
CN111528219A (en) * | 2020-05-13 | 2020-08-14 | 上海市计量测试技术研究院 | Freeze-drying protective agent for T lymphocyte subpopulation counting standard substance and application thereof |
CN111965344A (en) * | 2020-08-25 | 2020-11-20 | 沈阳瑞好生物科技有限公司 | Freeze-dried magnetic particle chemiluminescence immunoassay kit and preparation method thereof |
CN213023169U (en) * | 2020-08-28 | 2021-04-20 | 东莞东阳光医疗智能器件研发有限公司 | Single-person freeze-dried chemiluminescence reagent immunological reagent tube |
CN112748058A (en) * | 2020-12-28 | 2021-05-04 | 上海宸安生物科技有限公司 | Multi-index mixed flow type antibody freeze-drying micro-core kit for single cell analysis |
CN115166252A (en) * | 2022-07-07 | 2022-10-11 | 泰州宸安生物科技有限公司 | Lymphocyte subset grouping and quantitative detection kit, detection method and application thereof |
-
2023
- 2023-03-20 CN CN202310268654.1A patent/CN116256513A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5759774A (en) * | 1988-05-18 | 1998-06-02 | Cobe Laboratories, Inc. | Method of detecting circulating antibody types using dried or lyophilized cells |
US20090061478A1 (en) * | 2006-01-30 | 2009-03-05 | Lene Have Poulsen | High-Speed Quantification of Antigen Specific T-Cells in Whole Blood by Flow Cytometry |
CN111528219A (en) * | 2020-05-13 | 2020-08-14 | 上海市计量测试技术研究院 | Freeze-drying protective agent for T lymphocyte subpopulation counting standard substance and application thereof |
CN111965344A (en) * | 2020-08-25 | 2020-11-20 | 沈阳瑞好生物科技有限公司 | Freeze-dried magnetic particle chemiluminescence immunoassay kit and preparation method thereof |
CN213023169U (en) * | 2020-08-28 | 2021-04-20 | 东莞东阳光医疗智能器件研发有限公司 | Single-person freeze-dried chemiluminescence reagent immunological reagent tube |
CN112748058A (en) * | 2020-12-28 | 2021-05-04 | 上海宸安生物科技有限公司 | Multi-index mixed flow type antibody freeze-drying micro-core kit for single cell analysis |
CN115166252A (en) * | 2022-07-07 | 2022-10-11 | 泰州宸安生物科技有限公司 | Lymphocyte subset grouping and quantitative detection kit, detection method and application thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117384289A (en) * | 2023-11-09 | 2024-01-12 | 济南金域医学检验中心有限公司 | Antibody combination and kit for detecting T cell large granule lymphocyte and application of antibody combination and kit |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5223398A (en) | Method for screening cells or formed bodies for enumeration of populations expressing selected characteristics | |
Du Bois et al. | Investigation and standardization of the conditions for micro‐lymphocyte cultures | |
CN112147326B (en) | Accurate detection kit for tumor immune cell subset typing | |
CN110412287A (en) | One kind being based on single celled immunocyte parting quantitative analysis method | |
WO2010140706A1 (en) | Biological and industrial operating systems | |
CN101310025A (en) | Systems and methods for enrichment of analytes | |
CN101305087A (en) | Devices and methods for magnetic enrichment of cells and other particles | |
US6159740A (en) | Method and apparatus for screening obscured or partially obscured cells | |
WO1998021593A1 (en) | SIMULTANEOUS HUMAN ABO AND Rh(D) BLOOD TYPING OR ANTIBODY SCREENING BY FLOW CYTOMETRY | |
EP1623007A2 (en) | Method and apparatus for preparing cell samples for intracellular antigen detection using flow cytometry | |
US5260192A (en) | Method and apparatus for screening cells or formed bodies with populations expressing selected characteristics utilizing at least one sensing parameter | |
CN112748058B (en) | Multi-index mixed flow antibody freeze-dried microchip kit for single cell analysis | |
CN116256513A (en) | Single-person mixed flow antibody freeze-dried microchip detection reagent tube and preparation and application thereof | |
US5231005A (en) | Method and apparatus for screening cells or formed bodies with populations expressing selected characteristics | |
McCoy, Jr | Handling, storage, and preparation of human blood cells | |
CN115166252A (en) | Lymphocyte subset grouping and quantitative detection kit, detection method and application thereof | |
AU618736B2 (en) | Automated analyzer and method for screening cells or formed bodies for enumeration of populations expressing selected characteristics | |
AU635020B2 (en) | Method and apparatus for screening cells or formed bodies with populations expressing selected characteristics utilizing at least one sensing parameter | |
EP0472522B1 (en) | Method for screening cells or formed bodies with populations expressing selected characteristics | |
Liu et al. | Functional analysis of human circulating immune cells based on high-dimensional mass cytometry | |
US20220155308A1 (en) | Lyophilized antibody panel | |
US6110730A (en) | Whole blood cell staining device | |
Richards et al. | Immunophenotypic analysis of PNH cells | |
Merah‐Mourah et al. | A Two‐Stage Flow Cytometry Strategy to Distinguish Single Cells from Doublets in Heterogeneous Cell Mixtures and Improve Cell Cluster Identification: Application to Human Monocyte Subpopulations | |
CN110726838A (en) | Circulating tumor cell bright field negative identification method based on immune microspheres |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20230613 |